# BUMETANIDE
> **ANDA213942** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2024-12-27
## Drug
- **FDA Application Number:** ANDA213942
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUMETANIDE
- **Generic name:** BUMETANIDE
- **Active ingredients:** BUMETANIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Limited
- **First approval:** 2024-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213942)
---
*MORVS · CC0 1.0*